OKYO Pharma OKYO
NASDAQ OKYO
$1.40 -0.07 (-4.76%)
At close: Oct 23, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Cash from Investing Activities (2026)

Updated

OKYO Pharma's Cash from Investing Activities came in at $1.2 billion for the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Cash from Investing Activities (2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma's Cash from Investing Activities was -$6.01 million.

  • Going back by year, Cash from Investing Activities was -$1.21 billion in the year ended Mar 31, 2025, -$5.92 billion in the year ended Dec 31, 2023 and -$2.28 billion in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -2.71 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -1.20 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.11 Bn
10 OKYO Pharma 962.06 Mn 935.28 Mn - 1.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.20 Bn
API Access

OKYO Pharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=OKYO&period=max&api_key=YOUR_API_KEY